Wainua is only available at specialty pharmacies. They will mail your auto-injector and sharps container to you. If you need help paying for Wainua, the drugmaker may be able to assist you.

WAINUA WAINUA (eplontersen) is a ligand-conjugated antisense oligonucleotide (LICA medicine designed to reduce the production of transthyretin, or TTR protein. 2,7 WAINUA has been approved in the ...

Wainua (eplontersen) is a brand-name injection that’s prescribed for nerve damage related to amyloidosis (buildup of amyloid protein). As with other drugs, Wainua can cause side effects, such as ...

WAINUA has been approved in the U.S. for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults (also referred to as ATTRv-PN).

Wainua™ (eplontersen) granted regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis. News release. Ionis Pharmaceuticals.

Learn about uses, side effects, dosage, and more for Wainua. It's a prescription drug used to treat nerve problems in adults with a certain genetic condition.

Analyst sees potential for Wainua sales in ATTR-PN alone, which will be a significant value driver. Ionis remains William Blair's top pick for 2024, and the analyst reiterates the Outperform ...

U.S. INDICATION for WAINUA™ (eplontersen) WAINUA injection for subcutaneous use 45 mg is indicated for treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.

The FDA has granted regulatory approval for WAINUA for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults, according to a press release. Wainua (eplontersen ...